Security key
09075P105
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 27,093,277
- Total 13F shares
- 17,642,933
- Share change
- +280,882
- Total reported value
- $117,491,802
- Put/Call ratio
- 126%
- Price per share
- $6.66
- Number of holders
- 83
- Value change
- -$7,226,324
- Number of buys
- 48
- Number of sells
- 43
Report period
Q2 2023
Institutions
83
Top holders
10
BTAI full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P105
Recent filing periods:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
16%
|
4,276,693
|
$79,803,091 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
7.7%
|
2,081,979
|
$38,849,728 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
6.5%
|
1,760,683
|
$32,854,345 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.1%
|
1,370,688
|
$25,577,038 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.9%
|
1,334,606
|
$24,903,748 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
1,063,974
|
$19,853,756 | — | 31 Mar 2023 | |
| Artemis Investment Management LLP |
13F
|
Company |
3.6%
|
981,472
|
$18,278,606 | — | 31 Mar 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
388,765
|
$7,254,355 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
383,129
|
$7,149,187 | — | 31 Mar 2023 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.3%
|
364,086
|
$6,793,845 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
340,925
|
$6,361,660 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.8%
|
217,991
|
$4,067,712 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
211,665
|
$3,949,669 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
163,650
|
$3,053,710 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.59%
|
160,289
|
$2,990,993 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.55%
|
149,112
|
$2,782,430 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.53%
|
143,893
|
$2,685,043 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.49%
|
133,014
|
$2,482,041 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.48%
|
130,089
|
$2,427,461 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.44%
|
118,975
|
$2,220,074 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.42%
|
113,770
|
$2,122,948 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
94,000
|
$1,754,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.31%
|
84,432
|
$1,575,501 | — | 31 Mar 2023 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.3%
|
80,295
|
$1,498,305 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
77,132
|
$1,439,283 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
61,981
|
$1,156,565 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.23%
|
61,730
|
$1,151,882 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.23%
|
61,432
|
$1,146,282 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
61,340
|
$1,145,000 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.21%
|
57,400
|
$1,071,084 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
56,023
|
$1,045,389 | — | 31 Mar 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.18%
|
49,311
|
$920,143 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.18%
|
47,611
|
$888,422 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.16%
|
42,300
|
$789,318 | — | 31 Mar 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.15%
|
40,000
|
$746,400 | — | 31 Mar 2023 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.15%
|
40,000
|
$746,400 | — | 31 Mar 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.14%
|
37,887
|
$707,000 | — | 31 Mar 2023 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.14%
|
37,000
|
$690,420 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
34,556
|
$644,815 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
33,490
|
$625,000 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
27,665
|
$516,229 | — | 31 Mar 2023 | |
| PROFUND ADVISORS LLC |
13F
|
Company |
0.1%
|
27,462
|
$512,441 | — | 31 Mar 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
27,006
|
$503,932 | — | 31 Mar 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
24,342
|
$454,222 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.09%
|
24,000
|
$447,840 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.09%
|
23,894
|
$445,862 | — | 31 Mar 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.07%
|
18,458
|
$344,426 | — | 31 Mar 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.07%
|
17,963
|
$335,190 | — | 31 Mar 2023 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.06%
|
17,480
|
$326,000 | — | 31 Mar 2023 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.06%
|
17,325
|
$323,285 | — | 31 Mar 2023 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q2 2023
As of 30 Jun 2023,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,642,933 shares.
The largest 10 holders included
FMR LLC, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Artemis Investment Management LLP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GEODE CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
96
Q2 2023 holders
83
Holder diff
-13
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.